Parnassus Investments, LLC Gilead Sciences, Inc. Transaction History

Parnassus Investments, LLC

$45.6 Billion
Q3 2024

A detailed history of Parnassus Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Parnassus Investments, LLC holds 1,151,874 shares of GILD stock, worth $106 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,151,874

Previous 1,432,811 19.61%

Holding current value

$106 Million

Previous $98.3 Million 1.79%

% of portfolio

0.21%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $18.7 Million - $23.6 Million	-280,937 Reduced 19.61%	1,151,874 $96.6 Million
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $753 Million - $918 Million	-10,519,246 Reduced 88.01%	1,432,811 $105 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $2.69 Million - $3.05 Million	36,686 Added 0.31%	11,952,057 $968 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $14.8 Million - $16.1 Million	-199,695 Reduced 1.65%	11,915,371 $893 Million
Q2 2023 Jul 31, 2023	BUY	$76.01 - $86.7 $9.74 Million - $11.1 Million	128,121 Added 1.07%	12,115,066 $934 Million
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $5.84 Million - $6.66 Million	-75,592 Reduced 0.63%	11,986,945 $995 Million
Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $18.4 Million - $26.4 Million	295,282 Added 2.51%	12,062,537 $1.04 Billion
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2.78 Million - $3.18 Million	46,699 Added 0.4%	11,767,255 $726 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $50.8 Million - $57.2 Million	880,418 Added 8.12%	11,720,556 $724 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $6.45 Million - $8.08 Million	111,363 Added 1.04%	10,840,138 $644 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $9.05 Million - $10.3 Million	-139,476 Reduced 1.28%	10,728,775 $779 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $4.3 Million - $4.64 Million	63,503 Added 0.59%	10,868,251 $759 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $30 Million - $32.3 Million	442,715 Added 4.27%	10,804,748 $755 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $309 Million - $337 Million	4,864,272 Added 88.48%	10,362,033 $714 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $119 Million - $136 Million	1,990,761 Added 56.77%	5,497,761 $355 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.07 Million - $1.22 Million	-18,824 Reduced 0.53%	3,507,000 $204 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $192,385 - $241,891	3,098 Added 0.09%	3,525,824 $223 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $50.6 Million - $58.7 Million	-699,386 Reduced 16.56%	3,522,726 $271 Million
Q1 2020 May 01, 2020	SELL	$62.63 - $80.22 $414 Million - $531 Million	-6,615,011 Reduced 61.04%	4,222,112 $316 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $43.4 Million - $47.7 Million	703,862 Added 6.95%	10,837,123 $704 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $74.2 Million - $81.9 Million	1,187,424 Added 13.27%	10,133,261 $642 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $255 Million - $286 Million	-4,128,718 Reduced 31.58%	8,945,837 $604 Million
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $143 Million - $160 Million	2,288,767 Added 21.22%	13,074,555 $850 Million
Q4 2018 Feb 05, 2019	BUY	$60.54 - $79.0 $18.1 Million - $23.7 Million	299,575 Added 2.86%	10,785,788 $675 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $644 Million - $713 Million	-9,040,689 Reduced 46.3%	10,486,213 $810 Million
Q2 2018 Aug 06, 2018	SELL	$64.88 - $75.68 $11.9 Million - $13.9 Million	-183,958 Reduced 0.93%	19,526,902 $1.38 Billion
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $40.1 Million - $48.9 Million	551,112 Added 2.88%	19,710,860 $1.49 Billion
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $33.1 Million - $38.8 Million	464,609 Added 2.49%	19,159,748 $1.37 Billion
Q3 2017 Nov 01, 2017	SELL	$72.11 - $85.47 $55.5 Million - $65.8 Million	-769,306 Reduced 3.95%	18,695,139 $1.51 Billion
Q2 2017 Aug 11, 2017	BUY	N/A	19,464,445	19,464,445 $1.38 Billion

Others Institutions Holding GILD

# of Institutions

1,940

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parnassus Investments, LLC with notifications on news.

Account

Parnassus Investments, LLC Gilead Sciences, Inc. Transaction History